Delisting riskPopularity #4,891
DRMA · NASDAQ · Biotechnology

Dermata Therapeutics (DRMA)

Developing Bioneedle-based skincare for consumer and professional channels.

$1.13
After hours+0.01 (+0.89%)
At close$1.12(−2.61%)